The Source for Neurovascular News and Education

October 18, 2019

 

While more research is needed, the available data suggest the benefits of surveillance far outweigh the risks.

 

Regular surveillance of unruptured intracranial aneurysms using computed tomography angiography (CTA) is associated with an excess cancer risk due to radiation exposure that is so small as to be far eclipsed by the risk of aneurysm rupture, according to a modeling analysis published online December 7, 2018, ahead of print in Stroke.

 

The study authors, led by Ajay Malhotra, MD (Yale School of Medicine, New Haven, CT), point out that unruptured intracranial aneurysms are being identified more often because of increased use of less-invasive imaging techniques with higher resolution. At the same time, the natural history of these aneurysms remains uncertain.

 

Current American Heart Association/American Stroke Association guidelines recommend follow-up involving magnetic resonance angiography (MRA) or computed tomography angiography (CTA) done “at regular intervals for patients managed without either surgical or endovascular intervention,” they point out. “However, the interval and duration of recommended follow-up are uncertain.”

 

Cumulative exposure to radiation is one concern surrounding repeated use of CTA for surveillance. Malhotra and colleagues say a reasonable surveillance protocol should not expose patients to an increased risk of cancer that outweighs the risk of aneurysm rupture.

 

For the study, they used a simulation-modeling approach to estimate the degree of increased cancer risk associated with radiation exposure from CTA surveillance for unruptured aneurysms. Each CTA performed as part of routine surveillance was assigned as a separate radiation exposure event. Malhotra et al used the Radiation Risk Assessment Tool, which is based on data from the BEIR VII report, to estimate the degree of increase cancer risk associated with each event.

 

Men and women starting surveillance imaging at 30, 40, and 50 years of age and receiving annual CTAs were considered as separate subgroups. As a comparison, the investigators also calculated the radiation-induced cancer risk in the same groups of patients, if they received CTAs every 2 and 5 years.

 

Based on their calculations, each CTA performed conveys an approximately 0.0026% excess lifetime cancer risk. CTA-associated excess cancer risk per exposure increased relatively more rapidly with the first 10 exposures and plateaued after the 44th exposure.

 

Cancer Risk Low Even in Highest-Risk Group

 

The major factors contributing to an elevated excess lifetime cancer risk were receiving CTA follow-up at a younger age, having more frequent CTA follow-up, having a longer CTA surveillance period, and being male.

 

The highest-risk group consisted of male patients receiving annual CTA follow-ups from age 30. In this group, the excess lifetime cancer risk was calculated to be 0.115% by age 81.

 

“Radiation-induced brain cancer incidence associated with [unruptured intracranial aneurysm] surveillance strategies is markedly low relative to the risk for aneurysmal rupture,” conclude the authors. They call for additional studies to further evaluate cost-effectiveness and utility of routine CTA surveillance.

 

Commenting on the study for Neurovascular Exchange, Joseph J. Gemmete, MD (University of Michigan, Ann Arbor), expressed surprise that the cancer risk was as low as the authors found it to be. On the other hand, he pointed out, those working in angiography suites have become increasingly aware of the risks associated with radiation exposure and are doing everything in their power to minimize it. This practice change, combined with newer machines that also minimize radiation exposure, are making imaging procedures far safer than they were in the past, he added.

 

Gemmete himself typically follows aneurysm patients using MRI and told NVX he has no plans to change that practice. He pointed out, however, that some patients, such as those with cardiac pacemakers, cannot undergo MRI. For such patients, CTA appears to be a safe option. “You don’t have to worry about [the increased risk of cancer],” he noted. “It’s real, but it’s so small that the benefits far outweigh the risks.”

 

 



Source:

Malhotra A, Wu X, Chugh A, et al. Risk of radiation-induced cancer from computed tomography angiography use in imaging surveillance for unruptured cerebral aneurysms. Stroke. 2018;Epub ahead of print.

 

Disclosures:

Malhotra and Gemmete report no relevant conflicts of interest.

 

 

 

Wednesday, August 21 2019

In addition, an infarct in a new territory did not emerge as an independent predictor of...

Read More »

Wednesday, August 21 2019

The procedure—a hybrid of surgical and endovascular techniques—offers low stroke rates and a short...

Read More »

Wednesday, August 21 2019

Hyperintense acute reperfusion marker on MRI portends worse outcomes and may help identify...

Read More »

Wednesday, August 21 2019

The prematurely stopped and underpowered trial failed to meet its primary endpoint but was...

Read More »

Wednesday, August 21 2019

But an outside source questioned the decision to lump CREST together with EVA-3S, SPACE, and ICSS.

Read More »

Friday, June 28 2019

The best outcomes were seen in patients with unfavorable arches—the authors say this deserves...

Read More »

Friday, June 28 2019

“We were relieved to see that results from this study are consistent with our experience,” but the...

Read More »

Friday, June 21 2019

This cost-effective strategy benefits both patients and the bottom line, according to a Canadian...

Read More »

Friday, June 21 2019

From the outset, choose the approach that is the most likely to be successful, a study author...

Read More »

Friday, June 14 2019

The findings highlight the need to continue to improve systems of care for large-vessel occlusion...

Read More »

Friday, June 14 2019

Complications were more common  when treating large/giant aneurysms, but it was still lower than...

Read More »

Monday, June 10 2019

The study might provide impetus for a randomized clinical trial in the United States, its...

Read More »